1. Kantarjian HM, O’Brien S, Smith TL et al. Results of treatment with hyper-CVAD, a dose-intensive regimen, in adult acute lymphocytic leukemia. J Clin Oncol. 2000;18:547–61.
2. Osumi K, Fukui T, Kiyoi H et al. Rapid screening of leukemia fusion transcripts in acute leukemia by real-time PCR. Leuk Lymphoma. 2002;43:2291–9.
3. Soekarman D, van Denderen J, Hoefsloot L et al. A novel variant of the bcr–abl fusion product in Philadelphia chromosome-positive acute lymphoblastic leukemia. Leukemia. 1990;4:397–403.
4. van der Plas DC, Soekarman D, van Gent AM, Grosveld G, Hagemeijer A. Bcr–abl mRNA lacking abl exon a2 detected by polymerase chain reaction in a chronic myelogeneous leukemia patient. Leukemia. 1991;5:457–61.
5. Tuszynski A, Dhut S, Young BD et al. Detection and significance of bcr–abl mRNA transcripts and fusion proteins in Philadelphia-positive adult acute lymphoblastic leukemia. Leukemia. 1993;7:1504–8.